🇺🇸 FDA
Patent

US 8633210

Triazole compounds useful as protein kinase inhibitors

granted A61PA61P1/16A61P11/06

Quick answer

US patent 8633210 (Triazole compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/16, A61P11/06, A61P17/06, A61P19/00